Drugs / SygeLIX-Coll-T
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05200000 | Jan 2020 → Jun 2023 | corneal ulcer | TBF Genie Tissulaire | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SygeLIX-Coll-T | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05200000 ↗ |
| Route | Topical | “used by the patient as eye drops” NCT05200000 ↗ |